Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
SoftwareOne shareholders scrap agreement to sell company to Bain
-
SoftwareOne shareholders scrap agreement to sell company to Bain
-
SoftwareOne shareholders scrap agreement to sell company to Bain
-
SoftwareOne shareholders scrap agreement to sell company to Bain
-
SoftwareOne shareholders scrap agreement to sell company to Bain
-
Form 144 AvidXchange Holdings, Filed by: BAIN CAPITAL VENTURE FUND 2014, L.P.
-
Form 144 AvidXchange Holdings, Filed by: BAIN CAPITAL VENTURE COINVESTMENT FUND, L.P.
-
Form 8-K Bain Capital Private For: Feb 29
-
Form X-17A-5/A BAIN CAPITAL DISTRIBUTOR For: Dec 31
-
Rocket Software Brings Modernization Without Disruption to Three Major Industry Events
-
Orum Connects to the Federal Reserve, Advancing U.S. Payment System
-
Form 10-K Bain Capital Specialty For: Dec 31
-
Bain Capital Specialty Finance (BCSF) Tops Q4 EPS by 1c
-
Form 8-K Bain Capital Specialty For: Feb 27
-
Bain Capital Specialty Finance, Inc. Announces December 31, 2023 Financial Results and Declares First Quarter 2024 Dividend of $0.42 per Share and Additional Dividends Totaling $0.12 per Share for 202
-
Form X-17A-5 BAIN CAPITAL DISTRIBUTOR For: Dec 31
-
Sparq Acquires Fast-Growing Nearshore Digital Engineering Firm
-
Jnana Therapeutics to Participate in Upcoming Investor Conferences
-
Keap Launches Keap Customer Community, an App for Business Growth and Connection
-
Private Equity Firms Recognized by BluWave’s 2024 Top PE Innovator Awards Point to Growth-Minded Action
-
Sanofi's (SNY) consumer health division attracting early interest from Advent, Blackstone and more - Bloomberg
-
The 29th Annual 2024 New York Sohn Investment Conference to Convene Top Hedge Fund Leaders and Global Investors on April 3 in New York City
-
Virgin Australia CEO Hrdlicka steps down ahead of IPO preparations
-
CongruityHR Appoints Mike Viola as Chief Executive Officer
-
Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors
-
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
-
Form 4 Kyverna Therapeutics, For: Feb 12 Filed by: Bain Capital Life Sciences III General Partner, LLC
-
Form SC 13G Kyverna Therapeutics, Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A NaaS Technology Inc. Filed by: Bain Capital Rise Education IV Cayman Ltd
-
Bain Capital Credit Announces $2 Billion of Financing Investments in 2023
-
Form 13F-HR Bain Capital Public Equi For: Dec 31
-
Form 13F-HR Bain Capital Public Equi For: Dec 31
-
Form 13F-HR Bain Capital Credit, LP For: Dec 31
-
Form SC 13G/A Bain Capital Specialty Filed by: BANK OF AMERICA CORP /DE/
-
Form SC 13G/A AvidXchange Holdings, Filed by: BAIN CAPITAL VENTURE FUND 2014, L.P.
-
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form SC 13G/A Flywire Corp Filed by: BAIN CAPITAL VENTURE FUND 2014, L.P.
-
Form SC 13G/A Canada Goose Holdings Filed by: Bain Capital Integral Investors 2008, L.P.
-
Form SC 13G/A Annexon, Inc. Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SC 13G/A Disc Medicine, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A Cara Therapeutics, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A Cabaletta Bio, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Partners For: Dec 31
-
Form 13F-NT Bain Capital Fund XI, For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-HR BAIN CAPITAL VENTURE For: Dec 31
